Report Fraud About Us What We Do

Belviq Cancer Class Action Investigation Belviq Weight Loss Pills Cause Cancer Consider The Consumer

Class Actions

Can Weight Loss Pills Cause Cancer? A Class Action Investigation Tries To Answer

About the Belviq Cancer Class Action Investigation

Belviq and Belviq XR, the weight-loss drugs manufactured by Eisai Inc., were recalled by the FDA for allegedly increasing cancer risk among its users according to a safety clinical trial. The FDA has reported a range of cancer types with pancreatic cancer, colon cancer, and lung cancer occurring more frequently among Belviq weight loss users. According to the study, the longer patients took lorcaserin the more that the imbalance of the incidence of cancer increased. If you are affected by these allegations, and would like more information about the Belviq Cancer Class Action Investigation, contact us today for help.

Contact Us

Can Belviq Weight Loss Pills Cause Cancer?

Belviq and Belviq XR are brand names of the generic drug Lorcaserin, manufactured by Eisai Inc. and originally developed by Arena Pharmaceuticals, which was approved by the U.S. Food and Drug Administration (FDA) in 2012 to be used as an adjunct (add-on) weight loss therapy.

The pill is intended to be used long-term in conjunction with a reduced-calorie diet and increased physical activity to lessen hunger cravings which allegedly leads to weight loss. It is used for adults with a body mass index (BMI) of 30, or a BMI of 27 with conditions, such as high blood pressure, high cholesterol, or Type 2 diabetes, that may increase cardiovascular risk.

Some of the noted side effects of the drug include:

  • Nausea
  • Dry mouth
  • Headache
  • Dizziness
  • Constipation
  • Tiredness
  • Easy bleeding/bruising
  • Enlarged breasts
  • Mental/mood changes
  • Suicidal thoughts
  • Low blood sugar

The weight-loss drug was initially rejected by an FDA panel in a 9-to-5 vote over concerns of safety and efficacy due to reports of tumors growing in rats exposed to the drugs during the study phase. Upon approval, the FDA required Eisai Inc. to conduct a clinical safety trial to monitor patients for cardiovascular risks, but the results have been startling.

Editor’s note on the Belviq Cancer Class Action Investigation:

This article is crafted to inform you about the Belviq Cancer Class Action Lawsuit. If you or a family member took the product and developed cancer, you may be eligible to join the class action lawsuit investigation. Send us a message for your case evaluation.

If you are considered eligible to be among the class of consumers described in the article above, you may eventually be able to participate in receiving any compensation the court may award.

Contact Us

We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join in on any potential consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.

Similarly, please check out our current list of Class Actions and Class Action Investigations, here.

Interested in articles like these? Become a subscriber below!

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Can Weight Loss Pills Cause Cancer? A Class Action Investigation Tries To Answer” yet. Be the first to speak your mind!

Leave a Reply